Cargando…
Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis
PURPOSE: Our purpose was to explore the prognosis of aggressive breast cancers of the HER2 oncogene amplification (HER2 +) and triple-negative (TN) subtypes detected by screening, as well as the prognosis of interval cancers (clinically due to symptoms between screening rounds) and cancers in screen...
Autores principales: | Alanko, Johanna, Tanner, Minna, Vanninen, Ritva, Auvinen, Anssi, Isola, Jorma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062374/ https://www.ncbi.nlm.nih.gov/pubmed/33420595 http://dx.doi.org/10.1007/s10549-020-06060-z |
Ejemplares similares
-
HER-2 positive breast cancer: decreasing proportion but stable incidence in Finnish population from 1982 to 2005
por: Köninki, Katri, et al.
Publicado: (2009) -
Determinants of the number of mammography units in 31 countries with significant mammography screening
por: Autier, P, et al.
Publicado: (2008) -
Volumetric breast density affects performance of digital screening mammography
por: Wanders, Johanna O. P., et al.
Publicado: (2016) -
Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4–1 and NRDP1, in primary breast cancer
por: Luhtala, Satu, et al.
Publicado: (2018) -
Non-cancer morbidity among Estonian Chernobyl cleanup workers: a register-based cohort study
por: Rahu, Kaja, et al.
Publicado: (2014)